Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist "PIXI-F"


Phase N/A Results N/A

Summary of Purpose

To obtain a better understanding on the comparative effectiveness of apixaban versus VKA (Vitamin K antagonist) for stroke prevention in patients with NVAF (Non-valvular atrial fibrillation) in a real-life setting.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2017.

12 Feb 2016 17 Feb 2016 1 Mar 2016 1 Mar 2016 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample


Not available